Cancer cell membrane cloaked nanocarriers: A biomimetic approach towards cancer theranostics

被引:10
作者
Patra, Paloma [1 ]
Rengan, Aravind Kumar [1 ]
机构
[1] Indian Inst Technol Hyderabad, Dept Biomed Engn, Sangareddy 502284, Telangana, India
关键词
Biomimetic nanocarriers; Cancer cell membranes; Theranostics; Homotypic adhesion; Drug delivery; PHOTODYNAMIC THERAPY; COATED NANOPARTICLES; PHOTOTHERMAL THERAPY; CAMOUFLAGED NANOPARTICLES; MAGNETIC NANOPARTICLES; MACROPHAGE-MEMBRANE; DELIVERY; METASTASIS; ADHESION; PLATFORM;
D O I
10.1016/j.mtcomm.2022.104289
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
In physiological systems, nanoparticles (NPs) disguised within cell membranes constitute unique biomimetic platforms which can imitate several membrane functionalities of the source cells from where they are isolated. Cell membrane cloaked NPs have been investigated in studies encompassing a diverse array of membranes originating from cancer cells, immune cells, red blood cells and macrophages. Cancer cell membrane-cloaked nanocarriers (CM NCs), that have the ability to transport therapeutics / diagnostics right within the tumour cells, are receiving increased attention. CM NCs combine bioactive cell surface adhesioncomponents with additional proteins to provide longer systemic circulation and cell-specific homing, resulting in increased intra-tumoral invasion and tumor-specific NC localization. As a consequence, these CM NCs are indeed being explored for a variety of applications, as well as in cancer theranostics. The crucial processes and difficulties involving the fabrication and characterization of CM NCs have been described in this review. The homologous binding mechanism of CM NCs investigated for effective tumour targeting, have been highlighted and the merits and drawbacks of existing pre-clinical applications of CM NCs for cancer theranostics are discussed.
引用
收藏
页数:16
相关论文
共 126 条
[1]   An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites [J].
Attia, Mohamed F. ;
Anton, Nicolas ;
Wallyn, Justine ;
Omran, Ziad ;
Vandamme, Thierry F. .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2019, 71 (08) :1185-1198
[2]   Cell membrane-coated nanocarriers: the emerging targeted delivery system for cancer theranostics [J].
Bose, Rajendran J. C. ;
Paulmurugan, Ramasamy ;
Moon, James ;
Lee, Soo-Hong ;
Park, Hansoo .
DRUG DISCOVERY TODAY, 2018, 23 (04) :891-899
[3]   Lipid-polymer hybrid nanoparticle-mediated therapeutics delivery: advances and challenges [J].
Bose, Rajendran J. C. ;
Ravikumar, Rramaswamy ;
Karuppagounder, Vengadeshprabu ;
Bennet, Devasier ;
Rangasamy, Sabarinathan ;
Thandavarayan, Rajarajan A. .
DRUG DISCOVERY TODAY, 2017, 22 (08) :1258-1265
[4]   Biofunctionalized nanoparticles: an emerging drug delivery platform for various disease treatments [J].
Bose, Rajendran J. C. ;
Lee, Soo-Hong ;
Park, Hansoo .
DRUG DISCOVERY TODAY, 2016, 21 (08) :1303-1312
[5]   Nanomedicine applied to translational oncology: A future perspective on cancer treatment [J].
Bregoli, Lisa ;
Movia, Dania ;
Gavigan-Imedio, James D. ;
Lysaght, Joanne ;
Reynolds, John ;
Prina-Mello, Adriele .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2016, 12 (01) :81-103
[6]   Liposomes Coated with Isolated Macrophage Membrane Can Target Lung Metastasis of Breast Cancer [J].
Cao, Haiqiang ;
Dan, Zhaoling ;
He, Xinyu ;
Zhang, Zhiwen ;
Yu, Haijun ;
Yin, Qi ;
Li, Yaping .
ACS NANO, 2016, 10 (08) :7738-7748
[7]   Strategies for advancing cancer nanomedicine [J].
Chauhan, Vikash P. ;
Jain, Rakesh K. .
NATURE MATERIALS, 2013, 12 (11) :958-962
[8]  
Chen H., 2021, HYPOXIC TUMOR E LIMI, DOI [10.1021/acsami.1c03010, DOI 10.1021/ACSAMI.1C03010]
[9]   Rethinking cancer nanotheranostics [J].
Chen, Hongmin ;
Zhang, Weizhong ;
Zhu, Guizhi ;
Xie, Jin ;
Chen, Xiaoyuan .
NATURE REVIEWS MATERIALS, 2017, 2 (07)
[10]   Cancer cell membrane cloaking nanoparticles for targeted co-delivery of doxorubicin and PD-L1 siRNA [J].
Chen, Mushi ;
Chen, Ming ;
He, Jiantai .
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2019, 47 (01) :1635-1641